Browse by Author or Creator
Group by: Item type | No Grouping
Number of items: 33.
Dick, Lindsay J and Gray, Andrew and Ram, Asha and Hume, Aileen and Parris, Caroline and Hogg, Philip J and Elliott, Moira A and Ford, Steven J and Halbert, Gavin W (2013) Elimination of the antimicrobial action of the organoarsenical cancer therapeutic, 4-(N-(S-glutathionylacetyl)amino) phenylarsonous acid, before finished product sterility testing. Journal of Pharmacy and Pharmacology, 65 (11). 1664–1669.
Halbert, Gavin and Elliott, Moira and Ford, Steven and Dick, Lindsay and Schmidt, Elke (2013) Improved pharmaceutical stability of a boronphenylalanine mannitol formulation for boron neutron capture therapy. European Journal of Pharmaceutical Sciences, 48. pp. 735-739. ISSN 0928-0987
Gray, Andrew and Dick, Lindsay and Elliott, Moira and Ford, Steven and Halbert, Gavin (2012) A comparative analysis of two different analysers used for determination of the Total Organic Carbon in pharmaceutical grade water. European Journal of Parenteral and Pharmaceutical Sciences, 17 (2). pp. 47-51. ISSN 0964-4679
Marenah, Lamin and Allen, Elaine and Mountford, Joanne and Holyoake, Tessa and Jorgensen, Heather and Elliott, Moira (2012) Investigation into omacetaxine solution stability for in vitro study. Biomedical Chromatography, 26 (5). pp. 545-547. ISSN 0269-3879
Elliott, Moira and Ford, S J and Prasad, E and Dick, L J and Farmer, H and Hogg, P J and Halbert, G W (2012) Pharmaceutical development of the novel arsenical based cancer therapeutic GSAO for phase I clinical trial. International Journal of Pharmaceutics, 426 (1-2). pp. 67-75.
Schmidt, Elke and Dooley, Neil and Ford, Steven J. and Elliott, Moira and Halbert, Gavin W. (2012) Physicochemical investigation of the influence of saccharide-based parenteral formulation excipients on l-p-boronphenylalanine solubilisation for boron neutron capture therapy. Journal of Pharmaceutical Sciences, 101 (1). pp. 223-232. ISSN 0022-3549
Dick, Lindsay and Dooley, Neil and Elliott, Moira A and Ford, Steven J and Gordon, Malcolm R and Halbert, Gavin W and Kerr, William J (2011) Boron phenylalanine and related impurities: HPLC analysis, stability profile and degradation pathways. Journal of Pharmaceutical and Biomedical Analysis, 56 (3). pp. 633-636.
Green, S. and Phoenix, B. and Mill, A. J. and Hill, M. and Charles, M. W. and Thompson, J. and Jones, B. and Ngoga, D. and Detta, A. and James, N. D. and Doran, J. and Graham, N. and Ghani, Z. and Wojnecki, C. and Halbert, G. and Elliott, M. and Ford, S. and Sheehan, T. M. T. and Vickerman, J. and Lockyer, N. and Croswell, G. and Boddy, A. and King, A. and Cruickshank, G. S. (2011) The Birmingham Boron Neutron Capture Therapy (BNCT) project : developments towards selective internal particle therapy. Clinical Oncology, 23 (3). S23-S24. ISSN 0936-6555
Iqbal, Zafar and Elliott, Moira and Watson, David and Holyoake, Tessa and Jørgensen, Heather (2011) Analysis of imatinib in bone marrow and plasma samples of chronic myeloid leukaemia patients using solid phase extraction LC-ESI-MS. Pakistan journal of pharmaceutical sciences, 24 (3). pp. 285-291. ISSN 1011-601X
Zhou, Peixun and Hatziieremia, Sophia and Elliott, Moira A and Scobie, Linda and Crossan, Claire and Michie, Alison M and Holyoake, Tessa L and Halbert, Gavin W and Jørgensen, Heather G (2010) Uptake of synthetic low density Lipoprotein by leukemic stem cells--a potential stem cell targeted drug delivery strategy. Journal of Controlled Release, 148 (3). pp. 380-387.
Dooley, N. and Ford, S. J. and Prasad, Elke and Elliott, M. and Halbert, Gavin (2010) Experimental scrutiny and project timelines : an example. Journal of Pharmacy and Pharmacology, 62 (10). pp. 1208-1209. ISSN 0022-3573
Elliott, Moira and Halbert, G.W. (2008) Maintaining a frozen shipping environment for Phase I clinical trial distribution. International Journal of Pharmaceutics, 346 (1-2). pp. 89-92. ISSN 0378-5173
Stanway, Susannah J and Purohit, Atul and Woo, L W Lawrence and Sufi, Saulat and Vigushin, David and Ward, Rebecca and Wilson, Richard H and Stanczyk, Frank Z and Dobbs, Nicola and Kulinskaya, Elena and Elliott, Moira and Potter, Barry V L and Reed, Michael J and Coombes, R Charles (2006) Phase I study of STX 64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitor. Clinical Cancer Research, 12 (5). pp. 1585-92. ISSN 1078-0432
Elliott, M A and Halbert, G W (2005) Maintaining the cold chain shipping environment for Phase I clinical trial distribution. International Journal of Pharmaceutics, 299 (1-2). pp. 49-54. ISSN 0378-5173
Jorgensen, H G and Allan, E K and Graham, S M and Godden, J L and Richmond, L and Elliott, M A and Mountford, J C and Eaves, C J and Holyoake, T L (2005) Lonafarnib reduces the resistance of primitive quiescent CML cells to imatinib mesylate in vitro. Leukemia, 19 (7). pp. 1184-1191. ISSN 0887-6924
Jørgensen, Heather G and Allan, Elaine K and Mountford, Joanne C and Richmond, Linda and Harrison, Simon and Elliott, Moira A and Holyoake, Tessa L (2005) Enhanced CML stem cell elimination in vitro by bryostatin priming with imatinib mesylate. Experimental Hematology, 33 (10). pp. 1140-6. ISSN 0301-472X
Ford, S J and Elliott, M A and Halbert, G W (2003) Use of mathematical derivatives (time-domain differentiation) on chromatographic data to enhance the detection and quantification of an unknown 'rider' peak. Journal of Pharmaceutical and Biomedical Analysis, 33 (4). pp. 563-570. ISSN 0731-7085
Jorgenson, H.G. and Elliott, Moira and Paterson, Sarah and Holyoake, Tessa and Smith, Kevin (2002) Further observations on the debated ability of AGP to bind imatinib. Blood, 100 (1). pp. 367-369. ISSN 0006-4971
Elliott, M A and Ford, S J and Walker, A A and Hargreaves, R H J and Halbert, G W (2002) Development of a lyophilised RH1 formulation : a novel DT diaphorase activated alkylating agent. Journal of Pharmacy and Pharmacology, 54 (4). pp. 487-492. ISSN 0022-3573
Jorgenson, H.G. and Elliott, M. and Allan, E.K. and Carr, C.E. and Holyoake, T.L. and Smith, K.D. (2002) Alpha1-acid glycoprotein expressed in the plasma of chronic myeloid leukemia patients does not mediate significant in vitro resistance to sTI571. Blood, 99 (2). pp. 713-715. ISSN 0006-4971
Jorgensen, H G and Elliott, M A and Priest, R and Smith, K D (1998) Modulation of sialyl lewis X dependent binding to e-selectin by glycoforms of alpha-1-acid glycoprotein expressed in rheumatoid arthritis. Biomedical Chromatography, 12 (6). pp. 343-349. ISSN 0269-3879
Elliott, M A and Elliott, H G and Gallagher, K and McGuire, J and Field, M and Smith, K D (1997) Investigation into the concanavalin A reactivity, fucosylation and oligosaccharide microheterogeneity of alpha(1)-acid glycoprotein expressed in the sera of patients with rheumatoid arthritis. Journal of chromatography. B, Biomedical sciences and applications, 688 (2). pp. 229-237. ISSN 1387-2273
Elliott, M A and Elliott, H G and McGuire, J and Smith, K D (1996) Regarding the specificity of Newcastle disease virus sialidase. Glycobiology, 6 (5). R5-R7. ISSN 0959-6658
Elliott, H G and Elliott, M A and Watson, J and Steele, L and Smith, K D (1995) Chromatographic investigation of the glycosylation pattern of alpha-1-acid glycoprotein secreted by the hepg2 cell-line a putative model for inflammation. Biomedical Chromatography, 9 (5). pp. 199-204. ISSN 0269-3879
ELLIOTT, H G and ELLIOTT, M A and WATSON, J and SMITH, K D (1995) The influence of cytokines on the glycosylation pattern of alpha-l-acid glycoprotein secreted by the HepC2 cell line. Biochemical Society Transactions, 23 (2). S164-S164. ISSN 0300-5127
McGuire, J M and Elliott, M A and Elliott, H G and Smith, K D (1995) The resolution of oligosaccharides by high ph anion-exchange chromatography. Carbohydrate Research, 270 (1). pp. 63-69. ISSN 0008-6215
ELLIOTT, M A and ELLIOTT, H G and MCLAUGHLIN, C M and STEWART, Y M and SMITH, K D (1995) The non-degradative isolation of α1-acid glycoprotein from normal and rheumatoid plasma. Journal of Carbohydrate Chemistry, 14 (4-5). pp. 643-652. ISSN 0732-8303
Conference or Workshop Item
Gray, Andrew and Dick, Lindsay and Elliott, Moira and Ford, Steven and Halbert, Gavin (2012) Comparative analysis of TOC and conductivity analysers as applied to pharmaceutical water analysis. In: UK Pharm Sci 2012, 2012-09-12 - 2012-09-14, Nottingham.
Elliott, M. A. and Schmidt, E. and Ford, S. J. and Halbert, G. W. (2010) Experiences of melt fill production of Fenretinide/Lym-X-Sorb (TM) hard gelatin capsules for Phase I clinical trial. In: UNSPECIFIED.
Jorgensen, Heather and Cosimo, Emilio and Elliott, Moira and Michie, Alison and Holyoake, Tessa and Halbert, Gavin and McCaig, Alison (2012) Targeting proliferating CLL cells with a novel synthetic low density lipoprotein drug delivery system. [Proceedings Paper]
Jorgensen, H G and Allan, E K and Mountford, J C and Richmond, L and Elliott, M A and Holyoake, T L (2004) Enhanced primary CML stem cell elimination by bryostatin priming with imatinib mesylate in vitro. [Proceedings Paper]
Holyoake, T L and Allan, E K and Mountford, J C and Richmond, L and Harrison, S J and Elliott, M A and Jorgensen, H G (2003) Pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line K562. [Proceedings Paper]
Elliott, M. A. and Halbert, G. W. (2004) Verification of a phase I clinical trial distribution network for cold storage materials. [Review]
This list was generated on Wed Dec 11 04:49:43 2013 GMT.